ABL1 and acute myeloid leukemia: Forty-nine patients with t(9;22) (q34.1; q11.2)/BCR::ABL1 among 5819 AML cases included in the DATAML registry between 2000 and 2021 were identified including 20 patients with de novo BCR::ABL1+AML (0.3%).